Stopping Mounjaro for a Month — Can You Restart, and What Happens?

What trials tell us happens when tirzepatide is stopped

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults over 72 weeks and showed average weight reductions of around 20–21% at the 15mg dose. That result depended on continuous treatment alongside a reduced-calorie diet and increased physical activity. A follow-up analysis of the semaglutide programme (a closely related GLP-1 medicine) found that roughly two-thirds of weight lost during treatment was regained within a year of stopping, a figure NICE references when discussing the chronic nature of obesity in its appraisal of tirzepatide. The pattern for tirzepatide is expected to be similar. The reason is straightforward: tirzepatide works by activating gut hormone receptors that reduce appetite and slow gastric emptying. Once you stop injecting, those effects stop too. There is no residual biological change that keeps weight off once the medicine is gone. That is not a flaw in the treatment, obesity is a chronic condition, and these medicines are licensed for long-term use, not short-course use.

A one-month gap sits in a clinically meaningful range, and if you are wondering whether using Mounjaro for just a month is a realistic option, it is worth understanding what that actually means in practice. It is long enough for the medicine to clear your system almost entirely (tirzepatide's half-life means levels drop substantially within a few weeks), and long enough for appetite to return to its pre-treatment baseline for many people. Some people feel the difference within days of their last dose.

Why re-titration after a break is the standard clinical approach

Starting back at a maintenance dose after a month away is not how restarts work in practice. Your prescriber will most likely bring you back at a lower dose (often 2.5mg or 5mg) and step up again over several weeks. The logic mirrors the original titration: your gut has lost its recent adaptation to the medicine, and jumping straight to a higher dose increases the risk of nausea, vomiting and other gastrointestinal effects. The NHS guidance on weight-management injections notes that the starting dose is a tolerability phase, and the same principle applies when restarting after a significant break.

The exact re-titration plan depends on how long you stopped, which dose you were on, and your clinical picture at the time of restart. There is no single universal answer, which is why a prescriber review is a required step, not a formality. At nume, every repeat prescription involves a fresh clinical review by a GPhC-registered Independent Prescriber, so a restart after a break follows the same path as any other prescription request.

It is worth gently clearing up one misconception here: some people assume that because Mounjaro is an injection you take yourself at home, it works like a vitamin supplement you can dip in and out of freely. It does not. It is a potent prescription medicine with a dose-response curve, and restarts are a clinical decision, not a personal one.

Practical reasons people pause, and how to approach each one

The most common reasons for a planned one-month break include surgery (you should always tell your anaesthetist and surgical team that you take a GLP-1 medicine, and your prescriber will advise on timing), travel to a destination where cold storage is difficult, a temporary illness that makes injecting impractical, or a financial pause. Each carries a slightly different clinical consideration.

Surgery is the most time-sensitive. NHS England guidance recommends informing your healthcare team well in advance because GLP-1 medicines affect gastric emptying, which has implications for anaesthesia. Your prescriber will advise on when to stop and when it is safe to restart, do not make that call unilaterally. For travel and storage questions, the Mounjaro SmPC sets out exact room-temperature windows; see the eMC listing for precise details rather than relying on general estimates. For a shorter unplanned gap, our page on stopping Mounjaro for two weeks covers what a briefer interruption typically means in practice.

If cost is part of the reason, it is worth understanding what is actually included in a legitimate private prescription before comparing prices. Our Mounjaro access page covers what to look for in a provider and what a transparent price should include.

What to do before you stop, and before you restart

Before pausing, speak to your prescriber. A planned break is manageable with the right preparation: you and your prescriber can agree a lower re-entry dose in advance, discuss what to expect with appetite, and flag any changes in your health that would affect the restart plan. Stopping without telling anyone leaves you without that safety net.

Before restarting, a clinical review is essential. Your weight, any new medicines, and any health changes since you stopped all matter. If you have been off Mounjaro for a month, your prescriber needs current information, not the picture from four or five weeks ago. You can find a fuller discussion of the restart process on our stopping and restarting Mounjaro page, and a broader overview of stopping and starting the medicine covers the range of scenarios people face. Our free consultation is the right starting point if you are working out what a break means for your treatment plan, a prescriber can talk through your specific situation the same day.